Absci vs Icon
Absci (ABSI) and Icon (ICLR) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $1.3B
- Last close
- $7.51
- 12 months
- +171.1%
- Market value
- $14.3B
- Last close
- $186.71
- 12 months
- +18.1%
At a glance
- By market value, Icon ($14.3B) is about 11 times Absci ($1.3B).
- Over the last 12 months Absci's share price moved +171.1% and Icon's +18.1%; against the S&P 500 that is +165.4 points and +12.4 points.
- In their last fiscal years Absci kept -4113.7% of revenue as net income and Icon 2.8%.
- In the last 90 days insiders reported 0 open-market purchases at Absci and 0 at Icon; members of Congress disclosed 0 trades in Absci and 0 in Icon.
- Next results: Absci Mar 22, 2027, Icon not announced.
Share prices on one chart
Absci and Icon, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Absci ABSINASDAQ · Services-Commercial Physical & Biological Research | Icon ICLRNASDAQ · Services-Commercial Physical & Biological Research | |
|---|---|---|
| Size and profitability | ||
| Market value | $1.3B | $14.3B |
| Revenue, last fiscal year | $2.8M | $8.25B |
| Net income, last fiscal year | −$115M | $229M |
| Net marginNet income as a share of revenue | -4113.7% | 2.8% |
| Free cash flow | −$94M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Absci different from Icon?
Absci (ABSI) is in Services-Commercial Physical & Biological Research on NASDAQ, with $2.8M of revenue in its last fiscal year and a net margin of -4113.7%. Icon (ICLR) is in Services-Commercial Physical & Biological Research on NASDAQ, with $8.25B of revenue in its last fiscal year and a net margin of 2.8%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Absci and Icon compare in size?
Icon has the larger market value: Absci $1.3B and Icon $14.3B, at the last close.
Whose share price rose more over the last 12 months, ABSI or ICLR?
Over the last 12 months Absci moved +171.1% and Icon +18.1%. Past price moves say nothing about the future.
Which has had more insider buying, Absci or Icon?
Since 2006, Absci insiders reported 15 open-market purchases against 0 for Icon. These are counts of what was filed, not a view on either stock.
Do members of Congress trade ABSI or ICLR?
In the last 12 months, members of Congress disclosed 0 trades in Absci (ABSI) and 0 in Icon (ICLR).
When did insiders last buy ABSI and ICLR?
Absci: Sep 24, 2025. Icon: no open-market purchase on record.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Absci pageIcon pageRare insider trades this weekAll comparisons
https://oqro.io/compare/absi-vs-iclr
